Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430001
Status:
UNKNOWN
Last Update Posted:
2008-05-09
First Post:
2007-01-30
Brief Title:
Vinorelbine Plus Trastuzumab vs Docetaxel Plus Trastuzumab as 1 Line Treatment for HER2 Positive Metastatic Breast Cancer
Sponsor:
Organization:
Danish Breast Cancer Cooperative Group